End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56 SEK | +2.94% |
|
+11.55% | +67.66% |
06-12 | EQL Pharma Receives Approval for Listing to Nasdaq Stockholm Main Market | MT |
05-15 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.66% | 149M | |
-45.65% | 8.72B | |
-26.18% | 6.55B | |
-7.49% | 6.05B | |
+85.61% | 4.84B | |
-3.80% | 4.57B | |
+5.73% | 4.3B | |
-26.42% | 4.27B | |
-18.65% | 2.59B | |
+161.11% | 2.54B |
- Stock Market
- Equities
- EQL Stock
- News EQL Pharma AB
- EQL Pharma Launches SEK91 Million Takeover Bid for Sensidose